跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,449 条关于
“ALK tyrosine kinase inhibitors”
全部
21,449
临床试验
11,644
药物
3,983
机构
98
资讯
5,724
6个月前
TRIANA Biomedicines' TRI-611 Receives FDA Fast Track Designation for ALK+ NSCLC Treatment
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
去年
Nuvalent to Present First Clinical Data for Next-Generation ALK Inhibitor NVL-655 at AACR-NCI-EORTC Symposium
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
上个月
Non-Tyrosine Kinase Inhibitors Market to Reach USD 18.7 Billion by 2036, Driven by Biomarker-Linked Oncology Approvals
去年
Precision Medicine Advances in Oncology: Targeted Therapies Show Promise in Multiple Cancers
去年
ESK981 Plus Nivolumab Fails to Show Antitumor Activity in Metastatic Castration-Resistant Prostate Cancer
去年
JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases
第 1 页，共 573 页
上一页
下一页
